OCEL
Price:
$2.7425
Market Cap:
$19.97M
Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering biological therapies for degenerative conditions. Their primary investigational product is Zofin, an acellular biological treatment sourced from perinatal material. This therapeutic is specifically processed to preserve its inherent microRNAs, without the inclusion of any artificial additives or diluents. Zofin is currently undergoing Phase I/II clinical evaluation for its efficacy against COVID-19. Beyond its core drug development, Organicell also offers independent educational, promotional, and marketing solutions to various healthcare sectors, including medical, anti-aging, and regene...[Read more]
Industry
Biotechnology
IPO Date
2016-03-01
Stock Exchange
OTC
Ticker
OCEL
According to Organicell Regenerative Medicine, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.57. This represents a change of -79.70% compared to the average of -7.72 of the last 4 quarters.
The mean historical PE Ratio of Organicell Regenerative Medicine, Inc. over the last ten years is -3.56. The current -1.57 PE Ratio has changed 4.30% with respect to the historical average. Over the past ten years (40 quarters), OCEL's PE Ratio was at its highest in in the October 2024 quarter at 7.11. The PE Ratio was at its lowest in in the April 2021 quarter at -46.14.
Average
-3.56
Median
-2.93
Minimum
-8.61
Maximum
-0.10
Discovering the peaks and valleys of Organicell Regenerative Medicine, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 802.35%
Maximum Annual PE Ratio = -0.10
Minimum Annual Increase = -97.46%
Minimum Annual PE Ratio = -8.61
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.06 | -13.95% |
| 2024 | -2.39 | 33.78% |
| 2023 | -1.79 | -48.40% |
| 2022 | -3.46 | -23.07% |
| 2021 | -4.50 | -47.68% |
| 2020 | -8.61 | 11.08% |
| 2019 | -7.75 | 744.55% |
| 2018 | -0.92 | 802.35% |
| 2017 | -0.10 | -97.46% |
| 2016 | -4.00 | -97.07% |
The current PE Ratio of Organicell Regenerative Medicine, Inc. (OCEL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.08
5-year avg
-2.84
10-year avg
-3.56
Organicell Regenerative Medicine, Inc.’s PE Ratio is greater than Kadimastem Ltd (-2.35), greater than OptiBiotix Health Plc (-1.57), greater than Rapid Dose Therapeutics Corp. (-2.86), greater than OKYO Pharma Limited (-12.90), greater than Noxopharm Limited (-3.88), less than Antisense Therapeutics Limited (-0.60), less than Sorrento Therapeutics, Inc. (-0.00), less than American Hemp Ventures, Inc. (0), less than Malachite Innovations, Inc. (3.62), less than TPCO Holding Corp. (-0.07),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.35 | $9.50M | |
| -1.57 | $20.06M | |
| -2.86 | $1.78M | |
| -12.90 | $22.73M | |
| -3.88 | $14.78M | |
| -0.60 | $19.64M | |
| -0.00 | $16.54M | |
| 0 | $16.47M | |
| 3.62 | $2.64M | |
| -0.07 | $20.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organicell Regenerative Medicine, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Organicell Regenerative Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Organicell Regenerative Medicine, Inc.'s PE Ratio?
How is the PE Ratio calculated for Organicell Regenerative Medicine, Inc. (OCEL)?
What is the highest PE Ratio for Organicell Regenerative Medicine, Inc. (OCEL)?
What is the 3-year average PE Ratio for Organicell Regenerative Medicine, Inc. (OCEL)?
What is the 5-year average PE Ratio for Organicell Regenerative Medicine, Inc. (OCEL)?
How does the current PE Ratio for Organicell Regenerative Medicine, Inc. (OCEL) compare to its historical average?